Public–Private Partnership Models for Improving Access to Affordable Medications for the Treatment of Non-Communicable Diseases
Non-communicable diseases (NCDs) represent a major global health burden, yet access to affordable medications remains limited, particularly in low- and middle-income countries (LMICs). Public–Private Partnership (PPP) models have emerged as a potential strategy to enhance medicine availability and affordability, but evidence on their effectiveness remains limited. This study aimed to evaluate the impact of PPP models on access to essential medications for the treatment of NCDs, focusing on medicine availability, stock-outs, pricing, and patient affordability. A quantitative cross-sectional s
read more..